The humanized mouse model of HIV latency as a preclinical tool for therapeutic vaccine and anti-latency agent development.

Medicine & Life Sciences

1. HIV 100%
2. Vaccines 63%
3. HIV Infections 45%
4. T-Lymphocytes 38%
5. Infections 29%
6. HIV-1 26%
7. Therapeutics 26%
8. B-Lymphoid Precursor Cells 24%
9. Viral Load 19%
10. Blood Cells 16%
11. Luxembourg 16%
12. Immune System 16%
13. Spleen 16%
14. Integrase Inhibitors 15%
15. Bone Marrow 15%
16. Lymph Nodes 14%
17. Viruses 13%
18. Immune Reconstitution 13%
19. Organoids 13%
20. Active Immunotherapy 13%
21. CD4-CD8 Ratio 12%
22. Costs and Cost Analysis 12%
23. Nylons 12%
24. Belgium 12%
25. Syringes 11%
26. Centrifugation 11%
27. Macaca mulatta 10%
28. Virus Replication 10%
29. Life Expectancy 10%
30. Primates 9%
31. Natural Killer Cells 9%
32. Tablets 9%
33. Dendritic Cells 9%
34. Suspensions 9%
35. Acquired Immunodeficiency Syndrome 8%
36. Monocytes 8%
37. Immunity 8%
38. University Hospitals 8%
39. B-Lymphocytes 7%
40. Transplantation 7%
41. Flow Cytometry 7%
42. Animal Models 7%
43. Food 7%
44. RNA 7%
45. Clinical Studies 7%
46. Quality of Life 6%
47. Polymerase Chain Reaction 6%
48. Inflammation 6%
49. DNA 5%
50. Lung 5%
51. Liver 5%
52. Health 5%